Gerald B. Appel

NewYork–Presbyterian Hospital — United States

Medicine · Health Sciences

88h-index31.1kcitations348works3.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Diseases and Glomerulopathies(188), Chronic Kidney Disease and Diabetes(62), Systemic Lupus Erythematosus Research(55), Complement system in diseases(33), Vasculitis and related conditions(32)

Publications342 total

A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
Nature Medicine·2025· 2 cited
Author Correction: Exome analysis links kidney malformations to developmental disorders and reveals causal genes
Nature Communications·2025Open Access
Exome analysis links kidney malformations to developmental disorders and reveals causal genes
Nature Communications·2025· 6 citedOpen Access
Exome-wide analysis of congenital kidney anomalies reveals new genes and shared architecture with developmental disorders
2024· 1 citedOpen Access
Genome-wide studies define new genetic mechanisms of IgA vasculitis
2024· 4 citedOpen Access
Value of Genetic Testing in a Glomerular Disease Center
Journal of the American Society of Nephrology·2024
MAJESTY: A Phase 3, Randomized, Open-Label, Active Comparator-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy
Journal of the American Society of Nephrology·2024· 3 cited
C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation
Clinical Journal of the American Society of Nephrology·2024· 11 cited
Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial
Nephrology Dialysis Transplantation·2024· 4 citedOpen Access
WCN24-342 ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19
Kidney International Reports·2024Open Access
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
Nature Communications·2023· 59 citedOpen Access
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
The Lancet·2023· 226 citedOpen Access
Atacicept in IgA Nephropathy (IgAN): Continued Protective Titers to Diphtheria and Tetanus and Balanced Infections vs. Placebo with a Focus on COVID-19
Journal of the American Society of Nephrology·2023
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
Kidney International·2023· 91 citedOpen Access
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
Mayo Clinic Proceedings·2023· 36 citedOpen Access
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study
American Journal of Kidney Diseases·2023· 11 citedOpen Access
Strong protective effect of the <i>APOL1</i> p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
2023· 3 citedOpen Access
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy
Clinical Journal of the American Society of Nephrology·2023· 43 citedOpen Access
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy
Nature Genetics·2023· 156 citedOpen Access
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine·2023· 131 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Vivette D. D’Agati(18), Fernando C. Fervenza(12), Glen S. Markowitz(10), Jai Radhakrishnan(9), Andrew S. Bomback(8), Sanjeev Sethi(8), Ellen M. Ginzler(7), Pietro A. Canetta(7), Agnes B. Fogo(6), Brad H. Rovin(6), Richard J. Smith(6), Surya V. Seshan(5), Charles E. Alpers(5), H. Terence Cook(5), Cynthia C. Nast(5), Richard Lafayette(5), John R. Sedor(5), Debbie S. Gipson(5), Daniel Cattran(5), Sharon G. Adler(5)